Skip to main content
. 2014 Jul 28;8:1029–1036. doi: 10.2147/DDDT.S63753

Figure 3.

Figure 3

MICs (μg/mL) of PAS nanocomposites as compared to PAS alone against Mycobacterium tuberculosis as determined using the MGIT with BD BACTEC™ MGIT™ 960 growth supplement for DST and measured by the MGIT™ 960 instrument.

Notes: Results were analyzed using unpaired t-tests with Welch’s correction of PAS-nanocomposite. $$$$: Nanocomposite C versus B. ##: Nanocomposite B versus A. #: Nanocomposite C versus A. *P<0.05; nanocomposite A versus PAS. **P<0.05; nanocomposite B versus PAS.

Abbreviations: DST, drug susceptibility testing; MICs, minimum inhibitory concentrations; MGIT, Mycobacteria Growth Indicator Tube; PAS, para-aminosalicylic acid.